
Nick Sundich
Kaili Resources (ASX:KLR): From $0.04 to $1.08 in a single day…what caused the exponential rise?
Kaili Resources (ASX:KLR) made one of the biggest one-day gains in recent memory yesterday (August 18), closing at $1.08 after…
Eli Lilly (NYSE:LLY): This US$700bn company is set to beat Novo Nordisk & Ozempic even with this month’s hiccup
For investors who missed the run in Novo Nordisk shares, Eli Lilly (NYSE:LLY) appeared to be the next best thing.…
Share buybacks: Are they a good sign or a waste of money?
Share buybacks are a controversial topic amongst investors. Some say it is a waste of money, others will welcome it…
ASX Health Care Stocks Under Trump: Who’ll Win and Who’ll Lose?
What does the next few years hold for ASX Health Care Stocks Under Trump? There’s no doubt that the health…
Underlying v Statutory results? There’s a big difference between the 2 – here’s how to tell
When companies report results every reporting season, you’ll hear underlying and statutory results. What is the difference between the two…
Here are 6 ASX stocks at 12 month highs, and whether it is time to buy
Here are 6 ASX stocks at 12 month highs! Liontown Resources (ASX:LTR) Liontown’s Kathleen Valley has been producing since…
Merck & Co (NYSE:MRK): Its a top 5 healthcare company, but needs to figure out its post-Keytruda future
Merck & Co (NYSE:MRK) is one of the world’s most prominent healthcare companies. The healthcare industry is perceived by many…
Helloworld Travel (ASX:HLO): Looking to make more money from less people than less money from more people
Helloworld Travel (ASX:HLO) is one of the smaller travel stocks on the ASX, capped at over $200m. Its last two…
5 ASX stocks to buy after rate cuts
With the RBA having delivered another rate cut (the 3rd of the current cycle), we would imagine investors are thinking…
If you’re looking at insurance stocks as a safe investment, here’s why you might be mistaken
Insurance stocks may appear to only be up there with the banks in terms of money ‘on the books’. But…
Electro Optic Systems (ASX:EOS): Its been a 3 months with a 300% share price spike and $125m contract win, but can the run last?
Electro Optic Systems (ASX:EOS) has quadrupled in just a few months, making it a >$900m company. It is no accident…
Chalice Mining (ASX:CHN): Its got 17Moz of 3E (Palladium, Platinum and Gold combined); so why the sell off?
Chalice Mining (ASX: CHN) has been the exploration story of the decade. All of the hundreds of explorers on the…
CDIs (Chess Depository Interests): Why are some ASX companies listed in this way?
Some ASX companies have their shares listed as CDIs, or ‘Chess Depository Interests’. This is particularly true with American companies listed…
Trump’s Big Beautiful Bill: Here’s what investors need to know and 5 ASX stocks that will be beneficiaries!
Since President Trump returned to the White House, everyone’s been watching what he’s been doing on tariffs, but we think…
Mastercard or Visa? Which of these 2 stocks appears more attractive?
Should you invest in Mastercard or Visa? It is a difficult question for investors to answer. These payment giants hold…
Atlassian (NDQ:TEAM): Will this Aussie home grown tech company be made or broken by the AI boom?
Are Aussie investors really poorer for not having Atlassian (NDQ:TEAM) on the ASX? While many of the ASX’s tech stocks…
Here are 5 ASX Indices other than the ASX 200 for Investors to Watch Eagerly
Here are 5 ASX Indices other than the ASX 200! ASX All Ordinaries The All Ordinaries is an indice…
ASX Semiconductor Stocks: An Ultimate Guide for Investors (2025 edition)
ASX Semiconductor Stocks are amongst the most complicated and volatile companies on the bourse, but also those with amongst the…
ResMed (ASX:RMD): Investors who bought the dip would be satisfied, but is there any growth left in this one?
ResMed (ASX:RMD) is one of the few ASX healthcare stocks that has successfully made it in the USA. And while…
ASX stocks that will last forever: Here are our Top 5!
Everyone is looking for ASX stocks that will last forever – in other words, stocks that won’t go bust and…
Imagion Biosystems (ASX:IBX) gets ready for Phase 2
It’s taken a while to get here, but the US medical device company Imagion Biosystems (ASX: IBX), which listed on…
Microsoft (NDQ:MSFT): There’s still a lot more growth left in this one
Microsoft (NDQ:MSFT) really needs no introduction. We all use its products in our everyday lives, it successfully transitioned from a…
St George Mining’s (ASX:SGQ) Araxa Project is next to the largest niobium mine on Earth, and a big few months await
St George Mining (ASX:SGQ): Araxa keeps getting bigger Thanks to its Araxa project, St George Mining is one of the…
What does your company’s auditor do and here’s why you should care: The Big Tender of 2025
Each and every ASX-listed company will have auditor. But what do they do? Why is it almost always one of…
5 crucial things to look for in the annual report of an ASX company that may give you an advantage over other investors
5 crucial things to look out for in the annual report of an ASX company! The ASX reporting season is…
Cettire shares are down over 90% from their all time high as investors worry for the firm’s future
It hasn’t been a good 18 months for Cettire shares. For a long time after the pandemic, eCommerce was one…
The $300m Star Entertainment rescue package promised it a lifeline, but its not a done deal and the company’s fate hangs in the balance
Back in April, a long awaited Star Entertainment rescue package was unveiled and the company was able to stave off…
How to make money from ASX ETFs? Here are 5 strategies to consider!
Ask anyone how to make money from ASX ETFs and you’ll be told it is just buying, holding and selling…
Want to find good software stocks? Here are 4 important traits you need to look for
Software stocks have provided amongst the highest returns of any ASX sector. There have been plenty of success stories in…
IperionX (ASX:IPX): It has become a A$1.7bn company, all thanks for US demand for titanium
Five years ago, IperionX (ASX:IPX) was just another small cap treading water with a market cap of $2.7m. Even in…
BSA (ASX:BSA): After losing NBN as a client and crashing 80% in February, investors suspect its salvaging hope from the wreck
BSA (ASX:BSA) crashed over 75% in one day back in February but is gradually recovering and its quarterly from earlier…
Boss Energy (ASX:BOE): Its Honeymoon Uranium Project is back in production! But FY26 isn’t expected to go to (the previous) plan
Boss Energy’s (ASX:BOE) South Australian project may be called Honeymoon, but it has been anything but that for investors. And…
Missed out on the Nvidia boom? Why not consider Nvidia suppliers that are publicly listed? Here’s our top 6!
If you want to benefit from the growth of Nvidia but don’t have the confidence that you’ll be able to…
Chinese steel demand is in irreversible decline and here’s why that’s bad news
Chinese steel demand is in irreversible decline. It is easy to either deny that is a fact or that it…
Meme stocks: Are they still something investors should care about in 2025?
Meme stocks have become a popular topic in recent years, especially within the investing community. We thought we’d take a…
Ansell (ASX:ANN): More volatile than you’d expect for a PPE maker
Ansell (ASX:ANN) makes latex PPE (Personal Protective Equipment), particularly gloves. Latex gloves are no bottles of Dom Perignon, but they…
Capital Gains Tax on Shares: Here’s How It Works And Whether Or Not the 50% Discount Could Be Wound Back
Capital Gains Tax on Shares is one of the most notable taxes investors will face. Here is Stocks Down Under’s…
Remuneration strikes matter: Just ask Macquarie! Here’s why they matter and how to get one at an AGM
At each AGM, remuneration strike is one of few notable things that may happen and make headlines. This is particularly…
Bapcor (ASX:BAP): Still recovering from 3 profit downgrades in less than a year, but could it be destined for better times?
We last wrote about Bapcor (ASX:BAP) in late May, nearly 12 months to the day it had just seen a…
Active investing: What is it, how is it different from passive investing and why isn’t it in vogue?
Active Investing – isn’t this a misleading term, as isn’t all investing a kind of ‘being active’ in the sense…
Codeifai (ASX:CDE): This company just hired this AI pioneer to its advisory board and investors are excited
Once known as YPB Group, Codeifai (ASX:CDE) caught the attention of investors yesterday over news it hired a ‘Former Nvidia…
As ASX Reporting Season for FY25 Looms: Here’s An Investors Ultimate Guide
ASX Reporting Season is almost upon us once again. It is the most important time of the year for investors,…
Coronado (ASX:CRN): Down 85% in a year as metallurgical coal prices tumble, does it have a future?
Coronado Global Resources (ASX:CRN) is a producer and seller of metallurgical coal (also known as coking coal). While thermal coal…
This ASX chip stock is expecting inaugural revenues in 2026!
Which will be the next ASX chip stock to do what Weebit Nano and BrainChip have done? Nanoveu is a…
ActivEX (ASX:AIV) finished yesterday up 185% all thanks to a 310koz gold resource
ActivEX (ASX:AIV) investors had a spectacular day yesterday. Any investor in a company that gained 185% in a day will…
Here’s why investors are eager for antimony stocks like Trigg Mining (ASX:TMG) and Zeus Resources (ASX:ZEU)
18 months ago, few investors would have paid attention to antimony stocks – but now it is a question of…
Is it possible for an investor to ‘time the market’ or is it just a myth?
Is it possible at all to time the market? Some will tell you it is possible, but they were probably…
Oracle Corporation (NYSE:ORCL): At >US$650bn, its double IBM and quadruple Adobe! All because investors like its AI potential
Oracle Corporation (NYSE:OCL) is one of the world’s largest software companies. Capped at $680bn (a figure 70% higher than 12…
Here’s how to use the PEG ratio to tell if a stock is overvalued relative to its growth
The PEG ratio (Price/Earnings to Growth) ratio is a useful way to tell if an ASX stock, or any stock…
An Investors’ Guide to Critical Minerals: What are they, why are they critical & how to invest in them?
Critical Minerals is the buzzword of the decade in the commodities sector. They’re not just any minerals, they are minerals…
Atomo Diagnostics investors are excited about their fair share from Lumos Diagnostics’ A$487m distribution deal
Wednesday 16 July 2025 was a great day for Atomo Diagnostics (ASX:AT1) investors as shares climbed up to 56% higher…
City Chic Collective (ASX:CCX): Is there any hope of a return to the glory days for the plus size fashion retailer?
City Chic Collective (ASX:CCX) shareholders who bought in late 2021 and have held the stock since would have seen just about…
Is the ASX 200 index overconcentration really as big a problem as its made out to be?
Index overconcentration is a term that’s existed for decades, but has come increasingly to the fore in the last year…
Calmer Co International (ASX:CCO) is expecting good things in FY26
Calmer Co International (ASX:CCO) closed out FY25 with $8m in revenue, which was 86% ahead of 12 months ago. As…
Scope One And Two Emissions: What Are They And Why They’re Important for Investors to Watch
Investors have long known that emissions have been a problem and increasingly scruitanised, but they may not know what so-called…
Sandfire Resources (ASX:SFR): Is Spain-focused miner the best way to play the copper trade?
Sandfire Resources (ASX:SFR) is one of the ASX’s largest companies wth exposure to copper, and in our view the best.…
Here are 5 ESG metrics to look at to give you an edge in investing!
Here are 5 ESG metrics to look at! 1. Employee Turnover Common criticisms of ESG metrics is that some have…
BPM Minerals (ASX:BPM): Picking up unfinished business from AngloGold Ashanti and IGO
Last week was a big week for BPM Minerals (ASX:BPM). It sold its Claw Gold Project to Capricorn (ASX:CMM) for…
What is a contrarian investor, who are some of the most famous ones and can I make money if I adopt this strategy?
What is a contrarian investor? Are they nobodies on the fringe of the market? Or are they the prophets you…
Here Are 4 Dogs of the ASX that will Bounce Back With a Vengeance in FY26, and 4 That Won’t
Have you ever heard the term Dogs of the ASX? It can either allude to the worst stocks in the…
Johns Lyng Group (ASX:JLG): Taking the easy way out with a $1.1bn buyout
The tenure of Johns Lyng Group (ASX:JLG) is ending with Pacific Equity Partners buying it out for $1.1bn after several…
Here are 9 of the most successful hedge fund managers of all time
To say the most successful hedge fund managers have made a lot of money from the stock market is an…
SDI (ASX:SDI): Will slow and steady win the race?
If you’re looking for a stock that’ll make you a fortune, SDI (ASX:SDI) might not be the best one for…
Orphan Drug Designation: What is it and why is it a big deal for biotech stocks?
While most small cap health stocks dream of commercialisation, healthcare companies at an early stage get excited about achieving Orphan…
ASX Real Estate Stocks Are Finally Out of the Doldrums: But These 6 Are Standing Above The Rest
FY25 was finally the year ASX Real Estate Stocks broke out of their post-COVID slump, netting an average return of…
Prescient Therapeutics (ASX:PTX): It has taken the plunge into a Phase 2 trial against T-Cell Lymphoma
There’s plenty of ASX oncology biotechs conducting clinical trials, but Prescient Therapeutics (ASX:PTX) is one of the closest to commercialisation.…
Botanix Pharmaceuticals (ASX:BOT): Did it deserve to crash over 50% earlier this week?
Botanix Pharmaceuticals (ASX:BOT) crashed over 50% back on Tuesday after an update that left investors disappointed. A crash of this…
How can an investor beat the market? Here’s how to go about it
You may’ve heard the expression to ‘beat the market’. What does this mean? Well, it depends on the context in…
How to create a passive income from stocks in FY26? Here are 5 strategies
Most people invest in stocks for capital gains (in other words for selling the stock for more than they bought…
Here’s why Kogan (ASX:KGN) should be on your watchlist for FY26
Kogan shares (ASX:KGN) have been volatile in the past couple of years, but is a better future ahead of it? At…
Here are Our 11 Top ASX Stocks to Buy in FY26: 1 From Each Sector!
It is a New Financial Year, so it’s time to outline 11 Top ASX Stocks to Buy in FY26. Why…
So you want to trade international stocks? Here’s 4 things to consider
Modern technology allows Australian investors to trade international stocks just like local shares. But going abroad might be daunting for…
What is a company’s profit margin and why is it crucial in FY26?
In the high inflationary environment we’re in, investors will hear companies talk about margins. What are companies talking about? Why are…
How to find undervalued stocks? Here are 3 useful tools to help start your search
How can investors find undervalued stocks? It is a fine art, but it’s not impossible. In this article, we recap…
Seek (ASX:SEK): One of the best ASX tech stocks, but strongly overvalued
Online employment marketplace Seek (ASX:SEK) may be formally categorised as ‘Media and Entertainment’ by the ASX, although it is difficult to…
ROIC: How useful is this metric and which 3 sectors generate the highest returns?
ROIC, or Return on Invested Capital, is a financial metric used to measure a company’s efficiency in generating profits using…
Aussie Broadband (ASX:ABB): A likeable telco that can reach for the skies again
Aussie Broadband (ASX:ABB) is a good illustration of a Telco stock you can like (as opposed to Telstra). Since listing on…
What are the best ASX shares for dividend investing? They all belong to these 4 sectors
What are the best ASX shares for dividend investing? It is difficult to pick individual stocks because dividends can fluctuate…
Does Dusk Group (ASX:DSK) smell undervalued? It all depends on what consumers do with their Stage 3 tax cuts
Dusk Group (ASX:DSK) purports to be Australia’s favourite home fragrance seller. But investors were not sharing the love for it…
Here’s why it is a terrific time to look at ASX biotech small caps, and 4 worth considering for FY26
It’s been a tough few years for ASX biotech small caps. Even in the last 18 months, the market recovered…
Does Macquarie Group (ASX:MQG) deserve its reputation as the ‘millionaires factory’? And will it continue into FY26?
Macquarie Group (ASX:MQG) has a reputation as the ‘millionaire’s factory’, and it did not just develop it by accident. Despite…
Is your company’s management good or bad? Here are 2 ways to judge
Management makes or breaks a company, especially a listed one. It is easy to look at a company’s past and…
Annual Recurring Revenue: Is it a useful metric or lipstick on a pig?
Annual Recurring Revenue (ARR), sometimes called Annualised Recurring Revenue, is a metric you’ll hear some ASX small caps use. What…
So your stock went into voluntary administration … Is it all over now or will you get any of your money back?
Voluntary administration – these are the two words that no investor wants to hear. What will happen next and will…
What does a CFO (Chief Financial Officer) do and how important are they?
Every ASX company has a Chief Financial Officer (CFO) in their C-suite. They are among the most important people in…
Clarity Pharmaceuticals (ASX:CU6) is off all time highs but is a $600m company! Is it the next Telix?
When we last wrote about Clarity Pharmaceuticals (ASX:CU6), in July last year, it was a multi-billion dollar company, less than…
Baby Bunting (ASX:BBN): FY25 has been better and investors are finally giving it recognition, but how long will the run last?
Baby Bunting (ASX:BBN) is the poster child for what’s been happening retailers in a cost of living crisis…on steroids. This…
How to invest your super in FY26
How to invest your super (short for superannuation) is a question that all Australians will need to answer. Everyone will…
Who are the most successful investors of all time? Here is our top 4
Who are the most successful investors of all time? This is a question up for debate although here are our…
AFT Pharmaceuticals (ASX:AFP): A gem of a dual-listed healthcare company
AFT Pharmaceuticals (ASX:AFP) may not spring to mind as the best company to have come out of New Zealand. Many…
R&D: Which companies spend the most on it and how do they set their budgets right?
R&D (Research and Development) is an important activity undertaken by ASX-listed companies of all kinds. This is most prominent in…
Things were going so well for Redox (ASX:RDX), Australia’s largest chemicals importer, until its 1H25 results
It was a golden run for chemical importer Redox (ASX:RDX) from when it listed on the ASX in July 2023…until…
Adairs (ASX: ADH): After copping a massive beating in 2022-23, shares are on their way back up
After shedding 75% between mid-2021 and mid-2023, Adairs (ASX: ADH) shares have been on a slow and steady recovery, more…
The MySuper Performance Test: Here’s why it is good for your personal super, but potentially bad for your ASX stock investments
In 2021, the MySuper Performance Test was introduced as part of the ‘Your Future, Your Super’ reforms. This was introduced…
Here are 5 ASX stocks vulnerable to AI: Should you sell them?
Let’s take a look at some ASX stocks vulnerable to AI. Because right now, investors are focused on stocks that…
Sovereign Wealth Funds: How do they work and how does Australia’s stack up?
In this article, we look at Sovereign Wealth Funds. They are worth knowing about because they have a bigger role…